The Lunaphore Immuno-Oncology Grant Program has been designed with the intention of helping in the research of immuno-oncology by providing innovative instruments based on a microfluidic technology to perform mIF staining. Dr. Rahman and Chowdhury Arif Jahangir won 1st prize for a project titled “Exploration of the Interplay between Master Transcriptional Regulators and Immune Cells within the Tumour Microenvironment of Breast Cancer AND Comparison of subcutaneous adipose tissue (SAT) inflammatory profiles in individuals with and without COVID-19 infection” is a LabSat® Research system. This system which offers ultra-rapid turnover time for multiplex staining, and will be embedded in the Precision Oncology Ireland tissue imaging platform.
-
Cancer Research News- Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers November 11, 2024
- NIH-funded scientists uncover clues to precancer and tumor biology October 30, 2024
- NIH clinical trial will test precision medicine treatments for myeloid cancers October 23, 2024
- New cancer diagnoses did not rebound as expected following pandemic September 24, 2024
- NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry September 16, 2024
- Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer September 16, 2024
- Immunotherapy approach shows potential in some people with metastatic solid tumors July 11, 2024
- For healthy adults, taking multivitamins daily is not associated with a lower risk of death June 26, 2024
- Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma June 19, 2024
- Inherited genetic factors may predict the pattern of X chromosome loss in older women June 12, 2024